demonstrated suggested inconclusive safety concern ongoing study display ongoing demontrated benefit only observational study
COVID 19 hospitalized
COVID-19 mild to moderate
miscellaneous
Cannabidiol Crippa ...
sabizabulin VERU-111

1 studies excluded by filtering options 2

5671 Aisa-Alvarez, 2020 210excludedrisk of bias not avaialble